- PR Newswire•17 days ago
INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving the Board of Momenta Pharmaceuticals, Inc. -- MNTA
NEW YORK, March 7, 2017 /PRNewswire/ -- Levi & Korsinsky announces it has commenced an investigation of Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA). On February 17, 2017, Momenta announced that a contracted ...
- Reuters•23 days ago
The U.S. Food and Drug Administration said Pfizer Inc's process for manufacturing sterile injectable drugs at a plant in McPherson, Kansas, was "out of control" and put patients at risk, according to a warning letter made public on Tuesday. In the Feb. 14 letter, the FDA said several products were contaminated with multiple foreign particulates and that the injectable antibiotic vancomycin had been compromised by cardboard pieces. The FDA warned the company it had failed to take corrective action.
- GlobeNewswire•24 days ago
Momenta Pharmaceuticals to Webcast Presentation at the Cowen and Company 37th Annual Health Care Conference
CAMBRIDGE, Mass., Feb. 28, 2017-- Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will present at the ...
MNTA : Summary for Momenta Pharmaceuticals, Inc. - Yahoo Finance
Momenta Pharmaceuticals, Inc. (MNTA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||10.00 x 100|
|Day's Range||13.38 - 13.90|
|52 Week Range||8.16 - 19.90|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-43.79|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|